1. received 3 doses of covid-19 vaccine 2. received 2 doses of covid-19 less than 6 months prior to the start of the trial 3. received a different covid-19 vaccine not available in australia 4. currently on immunosuppressive medication or anti-cancer chemotherapy 5. hiv infection 6. congenital immune deficiency syndrome 7. has received immunoglobulin or other blood products in the 3 months prior to vaccination 8. study staff and their relatives 9. have a history of a severe allergic reaction to any covid-19 vaccines or have a medical exception to receiving further covid-19 vaccines 10. cannot read or understand english

1. received 3 doses of covid-19 vaccine 2. received 2 doses of covid-19 less than 6 months prior to the start of the trial 3. received a different covid-19 vaccine not available in australia 4. currently on immunosuppressive medication or anti-cancer chemotherapy 5. hiv infection 6. congenital immune deficiency syndrome 7. has received immunoglobulin or other blood products in the 3 months prior to vaccination 8. study staff and their relatives 9. have a history of a severe allergic reaction to any covid-19 vaccines or have a medical exception to receiving further covid-19 vaccines 10. cannot read or understand english

received 3 doses of covid-19 vaccine received 2 doses of covid-19 less than 6 months prior to the start of the trial received a different covid-19 vaccine not available in australia currently on immunosuppressive medication or anti-cancer chemotherapy hiv infection congenital immune deficiency syndrome has received immunoglobulin or other blood products in the 3 months prior to vaccination study staff and their relatives have a history of a severe allergic reaction to any covid-19 vaccines or have a medical exception to receiving further covid-19 vaccines cannot read or understand english

received 3 doses of covid-19 vaccine received 2 doses of covid-19 less than 6 months prior to the start of the trial received a different covid-19 vaccine not available in australia currently on immunosuppressive medication or anti-cancer chemotherapy hiv infection congenital immune deficiency syndrome has received immunoglobulin or other blood products in the 3 months prior to vaccination study staff and their relatives have a history of a severe allergic reaction to any covid-19 vaccines or have a medical exception to receiving further covid-19 vaccines cannot read or understand english